Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 + Oxaliplatin vs S-1 + Cisplatin in Advanced Gastric Cancer
NCT01824459Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Apr 2013
- Primary completion
- Dec 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of oxaliplatin in gastric adenocarcinoma and gastroesophageal junction adenocarcinoma (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Overall Survival. Started Apr 2013; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric adenocarcinomagastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NCT01824459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824459.